The Virga Law Firm Joins "Walk in My Shoes" to Raise Awareness for Domestic Violence and Sexual Abuse in Panama City Beach
The Virga Law Firm, P.A., team will be walking in the Panama City leg of the journey on Saturday, April 26, 2025, alongside community members and local partner, the Gulf Coast Children's Advocacy Center. The initial two-mile loop will begin and end at the Gulf Coast CAC, located at 210 E 11th St, Panama City, FL 32401, with a meeting time of 8:30 AM.
This cause holds deep significance for long-time family law attorney Gerard Virga, who emphasizes the importance of community involvement and awareness in the fight against abuse. 'At The Virga Law Firm, we believe in standing up for the most vulnerable members of our community. Events like this remind us all of the power of support, education, and solidarity,' said Virga.
With over 20 years of experience advocating for Florida families, The Virga Law Firm, P.A., is committed to promoting a safer, more informed community. The firm encourages clients, friends, and community members to join them in supporting this vital cause.
To sign up for the Panama City walk, please visit: https://runsignup.com/Race/FL/PanamaCity/WalkInMyShoesPanamaCity
For more information about the walk and Lauren's Kids, visit:http://laurenskidswalk.org
Together, we can make a difference, one step at a time.
For press inquiries, reach out to Marketing Director Mary Virga at mary.virga@thevirgalawfirm.com.
The Virga Law Firm, P.A., is a Florida-based family law practice dedicated to compassionate advocacy and legal excellence. The firm provides trusted counsel in divorce, custody, and all areas of family law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
Don't Sweat It: New Electric Era EV Chargers Help Cut Carbon Emissions and Save Energy, So You Can Keep Cool This Summer
Electric Era's patented battery backed power-conditioned DC fast chargers eliminate peak grid load for more energy efficient charging and reduced utility grid impact and energy costs. SEATTLE, Aug. 13, 2025 /PRNewswire/ — As sweltering summer heat waves crisscross America, one EV charging company is doing its part to be a good neighbor and helping homeowners stay cool by using 70% less peak energy to charge vehicles at nearby stores and shopping malls. That's important as the average homeowner will shell out nearly $800 this summer to stay cool – a 6% increase over last year. It's a vicious cycle as electric utilities scramble to meet peak demand by building more carbon-emitting peaker generators, passing costs on to customers. To help mitigate peak power demand and save nearby utility customers money on their energy bills, the Seattle-based Electric Era EV charging system manufacturer developed a patented battery-backed DC fast charger that cuts peak power consumption up to 70% – enough to give back the equivalent of 700 homes worth of power. 'No matter what you drive, whether it's an EV or gas vehicle, homes and businesses shoulder the costs to expand the electric grid. That's why we designed our EV chargers to significantly reduce the impact on the local energy grid,' said Electric Era CEO Quincy Lee. 'Our goal is to cut the carbon emissions that lead to higher summer temperatures without having a negative financial impact on the communities we serve.' Serving Local EV Customers Without Increasing Electric CostsMinimizing peak power demand was top-of-mind last year when the State of Washington and the Snohomish County Public Utility District (SNOPUD) evaluated competing level-3 charging options to use for the state's Climate Commitment Act program. They chose Electric Era for their first co-funded DCFC installation in Arlington, WA, in part, because the company was able to install an eight-stall 200 kW charging system using existing electric infrastructure. Not only did that save nearby rate payers money, it also dramatically reduced the amount of time it took for Electric Era to install the chargers – from years to just eight months. It also cut operating costs upwards of 70% for EV charge site developer Skycharger, by drawing power from both the battery and the grid simultaneously to cut peak demand charges. 'The project's use of innovative battery technology made it possible to provide power to the chargers without the need for increased capacity or expensive upgrades,' utility spokesperson Aaron Swaney said. 'We're thrilled that Electric Era will help us support EV customers in our service area with minimal impact on our residential and business customers.' Shave the Peaks, and Save the Ice CreamThe 'secret sauce' behind Electric Era's DC fast chargers is the battery-backed power conditioning that shaves off peak energy loads when customers charge their cars with a low state of charge (near empty for gas cars). Peak power is what electric utilities design for – and it's what drives up nearby electric utility costs, and adds months, if not years, to the time it takes to install Level-3 DC fast charging systems, which is critical to expanding EV use in the U.S. The idea of peak power reduction is not new, but making it work successfully from the charger location is, and many states are looking into what they call 'grid supportive transportation electrification' to use power conditioning systems like Electric Era's to minimize grid expansion expenditures and to use less high carbon-emitting peaker power plants. A 2023 Distribution Grid Electrification study by the California Public Advocates (CPA) Office estimates that expanding the state's electric grid to support EV charging alone might cost up to $51 billion over the next decade, however, those costs could be cut in half by shifting EV charging away from peak demand times and using power conditioned EV chargers to 'shave off' peak power loads. Load balancing is expected to become a key ingredient to breaking down the barriers to EV adoption by mitigating the impact of EV charging on the nation's antiquated electric grid – and further slowing the cycle of carbon emissions causing record summer temperatures, leading to more energy consumption and higher electric costs for consumers and small businesses. 'The notion that the nation's electric grid cannot handle the load of EVs is another myth that's ready to be busted,' Lee said. 'Yes, we can have lower carbon transportation and we can also have air conditioning and cold ice cream – it doesn't need to be an either-or proposition.' About Electric EraWith a vision to accelerate the world into the electric era of zero-emissions transportation through rapid innovations and market disruption, Electric Era is the only full-service EV charging solutions provider focused on the rapid deployment of highly reliable Level-3 DCFC systems at retail locations to grow and extend their retail space. Electric Era's patented battery-backed charging architecture and bespoke, private-label charging solutions deliver industry-leading power and reliability in a package that dramatically reduces installation time and energy costs. Learn more at Electric Era on X: @ElectricEraTechFollow Electric Era on LinkedIn: Linkedin/company/electric-era
The Star
2 hours ago
- The Star
Saudi Aramco signs 11 bln USD lease-and-leaseback deal for Jafurah gas assets
RIYADH, Aug. 14 (Xinhua) -- Saudi Aramco announced Thursday the signing of an 11 billion U.S. dollar lease-and-leaseback agreement for its Jafurah gas processing assets with a consortium of international investors, marking a major inflow of foreign direct investment into the Kingdom's energy sector. The deal is led by funds managed by Global Infrastructure Partners (GIP), a part of New York-based global investment management corporation BlackRock, the company revealed in a statement. Jafurah is the largest non-associated gas development in Saudi Arabia. It is a key component in Aramco's plans to increase gas production capacity by 60 percent between 2021 and 2030, to meet rising demand. As part of the transaction, a newly-formed subsidiary, Jafurah Midstream Gas Company (JMGC), will lease development and usage rights for the Jafurah Field Gas Plant and the Riyas NGL Fractionation Facility, and lease them back to Aramco for 20 years. JMGC will receive a tariff payable by Aramco in exchange for granting Aramco the exclusive right to receive, process, and treat raw gas from Jafurah. Aramco will hold a 51 percent majority stake in JMGC, with the remaining 49 percent held by investors led by GIP. The transaction, which will not impose any restrictions on Aramco's production volumes, is expected to close as soon as practicable, subject to customary closing conditions.
The Star
2 hours ago
- The Star
China pharma firms turn to local reagent suppliers to cut costs
PHARMACEUTICAL research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers say, as they seek to cut costs and delivery times. Western reagent suppliers including US-based Thermo Fisher Scientific and Germany's Merck have profited in the world's second-largest pharmaceutical market from the compounds used in lab tests for analysis and quality control. But rising Chinese import tariffs due to the trade war with the United States and longer-term concerns about costs or access are spurring Chinese companies to request products from local rivals like Shanghai Titan Scientific and Nanjing Vazyme Biotech instead, the executives and managers said. The five who spoke to Reuters work at Chinese firms involved in the purchase or supply of reagents and their comments are an early sign of an expected industry shift toward more Chinese purchases. China's reagent market for lab and diagnostic use has been to some extent supplied by imports, which were valued at US$5.76bil in 2024, down slightly from US$5.83bil in 2023, according to UN Comtrade data. 'It is actually more advantageous (for reagents to be local) because the timeliness requirement is high,' said Ma Xingquan, co-president of pharmaceutical research firm ChemPartner PharmaTech. Most reagents it uses in its pre-clinical work are products that are made in China by firms including Titan and Shanghai Aladdin Biochemical Technology, he said. ChemPartner's usage of locally made reagents would probably increase further as new products become available, Ma added. The rush to use domestically made reagents has accelerated since April, the month China raised duties on US goods to 125%, a manager at Titan and an executive at Vazyme said, though the levies have since been lowered as Beijing and Washington continue trade talks. Some Chinese drugmakers were worried about tariff policy uncertainty, Titan product manager Yang Dong said. Since April, more than 90% of Vazyme's customers have discussed replacing imported reagents with its products, Vazyme senior vice-president Xu Xiaoyu said. 'Before April, customers were only saying long term, they hope to be able to replace (reagents) with those locally made, it would be better,' Xu said. 'But to customers these tariffs are like a shock in a short period of time. They clearly felt this type of direct impact ... their impetus (for replacement) will be stronger.' Titan and Vazyme are both forecast to report strong sales growth this year, according to brokers. China International Capital Corp expects Titan's annual revenue to grow 22% to 3.52 billion yuan (US$490mil) this year, while Vazyme's revenue is set to rise 15% to 1.59 billion yuan over the same period, according to Soochow Securities. 'There is still a lot of room for substitution of imported biological reagent enzymes, clients are strongly interested in locally-made replacements,' Soochow said in a recent note. Shares in Titan and Vazyme have risen about 54% and 18% respectively since the start of the year. Merck and Thermo Fisher shares have fallen about 21% and 8% respectively over the same period. Morningstar analyst Max Jousma expects China's reagents market to grow more than 10% annually over the next five years, driven by government support for the biotech and pharmaceutical sectors and growth in research and development activity and in-vitro diagnostic testing. Merck and Swiss diagnostics group Roche Holding are moving some of their reagent production closer to their Chinese customers. In 2023, Merck announced plans to invest €70mil (US$81mil) in a reagents facility in Nantong that is on track to begin operations next year. Merck declined to comment on any short-term shifts in ordering patterns from Chinese customers. 'The decision to invest in reagent manufacturing in Nantong reflects our commitment to supporting the growing needs of life science and biopharma customers in China and the broader Asia-Pacific region,' it said in a statement. Roche is expanding production, laboratory and logistics facilities from 2028 in Suzhou, where it produces reagents for diagnostic systems, the company said in a statement. The expansion will help it meet increasing demand for diagnostic solutions in China and parts of Asia-Pacific, it said. — Reuters Andrew Silver writes for Reuters. The views expressed here are the writer's own.
